Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-22-001165

10% owner bought 20,047 shares at an average $5.20 ($104,212)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cambrian BioPharma Inc 10% owner 2022-01-11 Purchase +10,845 $5.18 $56,177 4,940,258 D: show line 1 in the form
Cambrian BioPharma Inc 10% owner 2022-01-12 Purchase +9,202 $5.22 $48,034 4,949,460 D: show line 2 in the form
Open-market purchases · 20,047 sh · avg $5.20 · $104,212
Loading xslF345X03/doc1.xml…